Viamet   Report issue

For profit Phase 2
Founded: Morrisville NC United States (2005)
Status: Acquired by Selenity Therapeutics (2018)

Organization Overview

First Clinical Trial
2013
NCT01891305
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (2)

fluconazole (diflucan) (1 trial)

oteseconazole (Vivjoa) (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Candidiasis (Phase 2)

Candidiasis, Vulvovaginal (Phase 2)

Onychomycosis (Phase 2)

Tinea (Phase 2)

Tinea Pedis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 2